Table 3.
Characteristics of Patients With FGID/DGBI
Subject no. | Age (y)/sex | Type of FGID/DGBI | D-Xylose, g/5 g/5 h (positive) | Hydrogen breath test | Hemoglobin (g/dL) | Albumin (g/dL) | B12 (pg/mL) | UGIE with biopsy |
---|---|---|---|---|---|---|---|---|
1 | 35/M | IBS-C | 0.55 | Negative | 15.5 | 5.3 | 432 | Normal |
2 | 68/M | Functional dyspepsia | 0.62 | Negative | 13.1 | 3.5 | 362 | Normal |
3 | 42/F | FAB/D | 0.91 | Negative | 13.3 | 4.1 | 214 | Normal |
4 (IMO) | 20/F | IBS-M/FD | 0.76 | Methane producer | 13.3 | 4.4 | 224 | Normal |
5 | 23/M | Functional diarrhea | 0.88 | Negative | 15.0 | 5.3 | 240 | Normal |
6 | 40/F | IBS-D/FD | 0.23 | Negative | 12.3 | 4.3 | 450 | Normal |
7 | 36/F | IBS-M | 0.42 | Negative | 12.3 | 4.1 | 1492 | Normal |
8 | 46/F | Functional dyspepsia | 0.88 | Negative | 14.0 | 4.9 | 422 | Normal |
9 (MAS) | 37/M | Functional dyspepsia | 0.96 | Negative | 13.8 | 4.1 | 186 | Normal |
FAB/D, functional abdominal bloating/distention; FD, functional dyspepsia; IBS-C, irritable bowel syndrome-constipation; IBD-D, irritable bowel syndrome-diarrhea; IBS-M, irritable bowel syndrome-mixed; IMO, intestinal methanogen overgrowth; MAS, malabsorption syndrome; UGIE, upper gastrointestinal endoscopy.